Chafic Karam
About
In The Last Decade
Chafic Karam
20 papers receiving 194 citations
Hit Papers
Peers
Comparison fields: 5 of 35
- Neurology 120
- Genetics 63
- Molecular Biology 44
- Surgery 38
- Infectious Diseases 32
Countries citing papers authored by Chafic Karam
This map shows the geographic impact of Chafic Karam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chafic Karam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chafic Karam more than expected).
Fields of papers citing papers by Chafic Karam
This network shows the impact of papers produced by Chafic Karam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chafic Karam. The network helps show where Chafic Karam may publish in the future.
Co-authorship network of co-authors of Chafic Karam
This figure shows the co-authorship network connecting the top 25 collaborators of Chafic Karam. A scholar is included among the top collaborators of Chafic Karam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chafic Karam. Chafic Karam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis breakdown → | 36 |
| 2 | 12 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 9 | |
| 6 | 31 | |
| 7 | 17 | |
| 8 | 5 | |
| 9 | 40 | |
| 10 | 9 | |
| 11 | 14 | |
| 12 | 1 | |
| 13 | 1 | |
| 14 | 1 | |
| 15 | 3 | |
| 16 | 2 | |
| 17 | 9 | |
| 18 | 4 | |
| 19 | 0 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.